Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

investorenquiries@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Phase I Monepantel Tablets Demonstrate High Safety

190326_Scaled tablet single dose safety performance (clean)

Category: News & Announcements 2019By PharmAust March 28, 2019

Related posts

31 December, Top 20 Shareholders
December 31, 2019

Expanded Site Recruitment for Monepantel Phase II Trial in Pet Dogs with Cancer
December 11, 2019

29 November, Top 20 Shareholders
December 2, 2019

Pitt Street Research Life Science Conference: Investor Presentation
November 28, 2019

Appendix 3B, Exercise of Options
November 19, 2019

Appendix 3B – Exercise of Options
November 8, 2019

Recent Articles

Notice of General Meeting
May 26, 2023
Motor Neurone Disease Clinical Trial Update
May 22, 2023
Progress update on Phase 1/2 MND interim analysis
May 16, 2023
Independent tests show MPL retains long-term shelf-life
May 10, 2023

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

pharmaust Follow

@ ·

now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter

Load More

Copyright © 2023 PharmAust. All rights reserved.

nil

Website Design & Digital Marketing Perth by Total Click Solutions